Instruction for use: Emoxipine

Dosage form: Eye drops, Solution for intravenous and intramuscular administration , solution for injection

Active substance: Methylaethylpiridinolum

ATX

C05CX Drugs that reduce the permeability of capillaries, others

Pharmacological group

Antiaggregants

Antihypoxants and antioxidants

Angioprotectors and microcirculatory correctors

The nosological classification (ICD-10)

H11.3 Conjunctival hemorrhage: Hemorrhages in the eye

H30 Chorioretinal inflammation: Retinitis; Chorioretinitis; Central and peripheral chorioretinal dystrophy

H34 Vascular occlusion of retina: Arterial thrombosis of the vessels of the eye; Venous thrombosis of the vessels of the eye; Violation of retinal circulation; Disturbances of intraocular circulation; Insufficient blood supply to the mesh and choroid; Occlusion of central retinal vessels; Acute obstruction of retinal arteries; Subacute and chronic circulatory insufficiency in the retina or in the choroid of the eye; Vascular diseases of the retina; Vascular disorders in the retina of the eye; Vascular thrombosis of the retina; Central retinal vein thrombosis; Thrombosis of the central vein of the retina and its branches; Thrombosis of the central vein of the retina of the eye and its branches

H35 Other retinal disease: retinal degeneration; Retinal degenerative changes in the eye; Subacute and chronic insufficiency of blood circulation in the retina or choroid

H35.6 Retinal hemorrhage: Hemorrhagic retinopathy; Hemorrhage in the retina; Hemorrhage in the retina of the eye; Repeated haemorrhage in the retina; Rota company; Hemorrhages in the eye; Hemorrhages in the retina at altitudes

H40 Glaucoma: glaucoma intervention; Afakicheskaya glaucoma; narrow-angle glaucoma; Chronic glaucoma; Chronic open-angle glaucoma; Wide-angle glaucoma

H43.1 Haemorrhage in the vitreous: Intraocular hemorrhage; Post-traumatic hemorrhage

I61 Intracerebral bleeding: apoplectic shock; Apoplexy of the brain; Hematoma subduralnoy; Hematoma epidural; Hemorrhagic stroke; Stroke apoplexy; Hemorrhagic stroke; Hemorrhage in the brain; Intra cerebral hemorrhage; Intra cerebral hemorrhage; Postponed hemorrhagic stroke; Subdural hematoma chronic; Epidural hematomas

I63 Cerebral infarction: ischemic Stroke; Ischemic brain disease; Ischemic stroke; Ischemic stroke and its consequences; Ischemic cerebral stroke; Ischemic cerebrovascular accident; Ischemic brain damage; Ischemic brain damage; ischemic conditions; Cerebral ischemia; Acute hypoxia brain; Acute cerebral ischemia; Acute ischemic cerebrovascular accident; Acute cerebral infarction; Acute ischemic stroke; Acute period of ischemic stroke; Focal cerebral ischemia; Ischemic stroke; recurrent stroke; The syndrome of Morgagni-Adams-Stokes; Chronic cerebral ischemia; cerebrovascular stroke; embolic stroke; Ischemic brain damage

Composition and release form

1 ampoule with 1 ml of injection contains 2-ethyl-6-methyl-3-hydroxypyridine hydrochloride (emoxipine) 0.01 g; In the package 5 pcs.

Pharmacology

Mode of action - Retinoprotective.

Protects the retina of the eye from the damaging effect of high-intensity light, promotes resorption of intraocular hemorrhages, reduces capillary permeability, reduces blood clotting, increases brain resistance to hypoxia and ischemia.

Indications for Emoxipine

Intraocular hemorrhages, diabetic retinopathy, central chorioretinal dystrophies, central vein thrombosis of the retina and its branches, posttraumatic hemorrhages, complicated myopathy, glaucoma, acute and chronic cerebrovascular disorders of ischemic and hemorrhagic nature. Protection of the retina of the eye from exposure to high-intensity light (laser and solar burns, laser coagulation).

Contraindications for Emoxipine

Hypersensitivity, pregnancy.

Side effects

Excitation (short-term), drowsiness, increased blood pressure, rash, local reactions: pain, burning sensation, itching, redness, denser parorbital tissues.

Dosage and Administration

Retrobulbarly - 0.5 ml of 1% solution once a day for 10-15 days; Parabulbar and subconjunctival - 0.2-0.5 ml once a day for 10-30 days. To protect the retina of the eye with laser coagulation, retrobulbarno is administered at 0.5 ml per day and 1 h before coagulation. Then, retrobulbarno is used for 0.5 ml for 2-10 days 1 time per day. In neurology - in / m 3-5 ml for 10-30 days 2-3 times a day.

Precautionary measures

It is not recommended to mix with other injections in one syringe.

Storage conditions of Emoxipine

In the dark place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life

3 years

Do not use beyond the expiration date printed on the package.